History

• 2009 - UTI works with representatives from Calgary Technologies Inc., the City of Calgary, and the University of Calgary to move towards completion of an implementation plan for Innovate Calgary, the working title for the creation of a new regional technology transfer and commercialization hub.
• 2009 - UTI helps researchers from the Schulich School of Engineering patent a device called the Electronic Mosquito, a skin patch that could one day provide a less invasive alternative for diabetics who need to take regular samples of their own blood.
• 2009 - UTI evaluates 56 inventions, files 55 patent applications, completes 18 deals, and grosses $5,711,583 in licensing and royalty revenue for the year ended March 31, 2009.
• 2009 - UTI ranks in the top three among Canadian institutions for gross licensing revenue, in the 2008 annual survey conducted by the Association of University Technology Managers (AUTM).
• 2008 - UTI and Tech Avenue Venture Corp. exercise an option to license and conclude a definitive license agreement for the MPowRx device, a clinically proven anti-snoring appliance.
• 2008 – UTI celebrates one year anniversary of its company creation capability – IGNITE – and announce over $6 million in financing for two companies.
• 2007 – UTI and BioAlberta enter into partnership focused on creating stronger technology-based companies within the Calgary region and improving the technology commercialization process for early stage technologies.
• 2006 - UTI launches its company creation and incubation capability, IGNITE.
• 2006 - UTI, in collaboration with TECEdmonton and Alberta Ingenuity, create Ingenuity Enterprise receiving funding of $3.2 million over three years.
• 2005 - UTI and U of C relationship formed into a legal partnership.
• 2005 - UTI team leads the formation and funding application for the development of the Southern Alberta Intellectual Property Network — a network created to mobilize technology commercialization efforts in southern Alberta.
• 2005 - BIOTECanada named SemBioSys 'Company of the Year' (SemBioSys Genetics Inc. is one of the longest surviving and most stable biotechnology companies to be incubated and launched by UTI).
• 2004 - UTI start up SemBioSys Genetics Inc. went public in December 2004, trading common shares on the Toronto Stock Exchange.
• 2003 - Another record for U of C disclosures – 78. UTI re-aligns its business units to parallel the U of C’s research strengths.
• 2002 - UTI sets a record for U of C disclosures – 62 – and records five spinouts.
• 2001 - UTI sets record for disclosures – 135 – and returns $300,000 to the U of C. In October, UTI moves its offices to the Alastair Ross Technology Centre in the University Research Park.
• 2000 - UTI records $4.6 million in revenue and returned $900,000 to the University of Calgary. UTI participates in the creation of WestLink and the Alberta Technology Commercialization Network.
• 1997 - In October UTI announced it was creating a series of $15,000 Fellowships for postgraduate and doctoral researchers.
• 1996 - UTI went online in June 1996 with the launch of its Web site – www.uti.ca. UTI brought its roster of startup companies to 10.
• 1990 - Early researchers included Dr. Anthony Schryvers, Dr. Klaus-Peter Schwarz, Dr. Elizabeth Cannon, Dr. John Remmers, Dr. Gèrard Lachapelle, Dr. Benno Nigg, Dr. Maurice Moloney and Dr. Michel Fattouche, all of whom became significant figures in Alberta’s high-technology community.
• 1989 June 1 - University Technologies International became operational, changing the way Canadian universities work in Canada’s technology transfer industry.